Recently two cases involving the amount of proof required to sustain criminal convictions for money laundering were decided before the United States Court of Appeals for the Sixth Circuit, based […]
In the August 2, 2010 edition of the Federal Register, the Bureau of Industry and Security (BIS) “ the Department of Commerces group in charge of export regulation in that […]
The U.S. Food and Drug Administration (FDA) has given the “go ahead” to the worlds first authorized human trial of a treatment derived from human embryonic stem cells. This trial […]
The next bank to draw the attention of the Internal Revenue Service (IRS) after the UBS investigation, on which we previously reported, is London-based HSBC. The Department of Justice (DOJ) […]
On July 23, 2010 the FDA approved the first generic enoxaparin product in a major policy advancement that will likely impact a number of other naturally sourced generic drugs and […]
As we previously reported, the Patient Protection and Affordable Care Act of 2010 (“PPACA”) contains a section requiring nutritional disclosure requirements for certain retail food establishments and vending machine operators. […]
Drug and medical device manufacturers need to be aware and comply with state and federal gift disclosure rules because a failure to comply, even if inadvertent, could mean hefty monetary […]
The Foreign Account Tax Compliance ACT (FATCA) is Congresss newest attempt to tackle tax evasion, specifically that which occurs through the utilization of offshore accounts. Nearly all provisions of the […]
On June 25, 2010, the United States Court of Appeals for the District of Columbia Circuit issued an opinion holding that two doctors who were applying to the National Institute […]
On Friday, July 16, the Department of Justice (DOJ) and Department of Health and Human Services (HHS) announced that the joint DOJ-HHS Medicare Fraud Strike Force has charged 94 people […]
